Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pelton

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Animal Science|March 1, 1993
Comparison of the fatty acid composition of subcutaneous adipose tissue from mature Brahman and Hereford cowsN O Huerta-Leidenz, H R Cross, J W Savell, et al.
The Journal of Pediatrics|January 1, 1993
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virusF D Boucher, J F Modlin, S Weller, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Animal Science|March 1, 1993
Comparison of the fatty acid composition of subcutaneous adipose tissue from mature Brahman and Hereford cowsN O Huerta-Leidenz, H R Cross, J W Savell, et al.
The Journal of Pediatrics|January 1, 1993
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virusF D Boucher, J F Modlin, S Weller, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
Pageof 4